Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID | |
Chemical and physical data | |
Formula | C10H11BrN2O |
Molar mass | 255.115 g·mol−1 |
3D model ( JSmol) | |
| |
|
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects. [1]